Background Motor disturbances and non-motor disturbances such as constipation are the
main factors affecting the quality of life in patients with Parkinson's disease (PD). We …

Cognitive impairment is one of the most salient non-motor symptoms of Parkinson disease
(PD) that poses a significant burden on the patients and carers as well as being a risk factor …

Patients with Parkinson's disease (PD) exhibit multifaceted changes in neurophysiological
brain activity, hypothesized to represent a global cortical slowing effect. Using task-free …

Pathophysiological substrate (s) and progression of Parkinson's disease (PD) with mild
cognitive impairment (PD-MCI) are still matter of debate. Baseline cerebrospinal fluid (CSF) …

There has been a lot of basic and clinical research on Alzheimer's disease (AD) over the last
100 years, but its mechanisms and treatments have not been fully clarified. Despite some …

Neurodegenerative diseases (NDs) affect millions of people worldwide, and to date,
Alzheimer's and Parkinson's diseases are the most common NDs. Of the many risk factors …

Neurodegenerative diseases (NDs) have been becoming a serious public health concern as
the world's population continues to ageing, demanding for the discovery of more effective …

Parkinson's disease (PD) is a chronic progressive neurodegenerative disorder
characterized by motor and non-motor disturbances as a result of a complex and not fully …

Parkinson's disease (PD) is a neurodegenerative disorder that affects millions of people
worldwide, and its incidence is expected to rise due to the aging of the global population …

Clinical populations with basal ganglia pathologies may present with language production
impairments, which are often described in combination with comprehension measures or …